Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Pediatrix Medical Group, Inc. (MD) had Stock-Based Compensation of $12.70M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$492.88M |
|
$71.71M |
|
$352.53M |
|
$140.35M |
|
$424.82M |
|
$68.05M |
|
$19.73M |
|
$87.78M |
|
$66.87M |
|
$71.71M |
|
$71.71M |
|
$71.71M |
|
$46.97M |
|
$68.05M |
|
$73.84M |
|
84.61M |
|
85.61M |
|
$0.85 |
|
$0.84 |
|
| Balance Sheet Financials | |
$717.20M |
|
$38.64M |
|
$1.48B |
|
$2.20B |
|
$392.55M |
|
$577.17M |
|
$916.19M |
|
$1.31B |
|
$890.67M |
|
$-379.56M |
|
$890.67M |
|
85.83M |
|
| Cash Flow Statement Financials | |
$156.99M |
|
$-8.01M |
|
$-38.86M |
|
$229.94M |
|
$340.06M |
|
$110.12M |
|
|
Stock-Based Compensation |
$12.70M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.83 |
|
-- |
|
-- |
|
0.39 |
|
0.68 |
|
28.48% |
|
13.81% |
|
13.81% |
|
-- |
|
17.81% |
|
14.55% |
|
$143.82M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
-- |
|
2.10 |
|
42.90 |
|
8.05% |
|
-18.89% |
|
3.26% |
|
4.89% |
|
$10.38 |
|
$1.68 |
|
$1.83 |
|